Pritesh Shah, Chief Growth Officer at NovoCure Ltd (NVCR), sold 3,846 shares at $76.36 ($294K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Seasonal sale ($294k) by Chief Growth Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.36 | 1,923 | $147K | 50.0% |
| 2 | $76.36 | 1,923 | $147K | 50.0% |
| Total | $76.36 avg | 3,846 | $294K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $42K | — | Filing → |